|
1
|
IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration.
|
Am J Physiol Gastrointest Liver Physiol
|
2006
|
3.72
|
|
2
|
Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults.
|
Gastroenterology
|
2013
|
2.71
|
|
3
|
Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours.
|
Eur J Nucl Med Mol Imaging
|
2004
|
2.45
|
|
4
|
International Union of Pharmacology. XXXV. The glucagon receptor family.
|
Pharmacol Rev
|
2003
|
2.25
|
|
5
|
Methylation of serum DNA is an independent prognostic marker in colorectal cancer.
|
Clin Cancer Res
|
2006
|
2.13
|
|
6
|
Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis.
|
Digestion
|
2002
|
2.09
|
|
7
|
IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression.
|
Am J Physiol Gastrointest Liver Physiol
|
2005
|
2.05
|
|
8
|
Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin.
|
Gut
|
2011
|
2.01
|
|
9
|
Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
|
Inflamm Bowel Dis
|
2008
|
1.96
|
|
10
|
Novel genetic risk markers for ulcerative colitis in the IL2/IL21 region are in epistasis with IL23R and suggest a common genetic background for ulcerative colitis and celiac disease.
|
Am J Gastroenterol
|
2009
|
1.96
|
|
11
|
Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.
|
Diabetes Res Clin Pract
|
2007
|
1.80
|
|
12
|
Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
|
Am J Gastroenterol
|
2009
|
1.80
|
|
13
|
Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.
|
Inflamm Bowel Dis
|
2010
|
1.69
|
|
14
|
Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.
|
Eur J Endocrinol
|
2009
|
1.66
|
|
15
|
Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status.
|
Inflamm Bowel Dis
|
2008
|
1.64
|
|
16
|
Glucose intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with impaired glucose-dependent insulinotropic polypeptide function.
|
Diabetes
|
2010
|
1.58
|
|
17
|
Safety aspects of infliximab in inflammatory bowel disease patients. A retrospective cohort study in 100 patients of a German University Hospital.
|
Digestion
|
2004
|
1.57
|
|
18
|
Pathophysiology of acute experimental pancreatitis: lessons from genetically engineered animal models and new molecular approaches.
|
Digestion
|
2005
|
1.56
|
|
19
|
rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
|
PLoS One
|
2007
|
1.48
|
|
20
|
CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation.
|
Exp Cell Res
|
2005
|
1.48
|
|
21
|
High prevalence and poor control of hypertension in primary care: cross-sectional study.
|
J Hypertens
|
2004
|
1.43
|
|
22
|
A new electrophysiological tool to investigate the spatial neuronal projections within the myenteric ascending reflex of the mouse colon.
|
Clin Exp Pharmacol Physiol
|
2008
|
1.39
|
|
23
|
The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells.
|
Neuroendocrinology
|
2007
|
1.31
|
|
24
|
The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumors.
|
J Nucl Med
|
2012
|
1.31
|
|
25
|
SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29.
|
Biochem Biophys Res Commun
|
2005
|
1.29
|
|
26
|
Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer.
|
Clin Gastroenterol Hepatol
|
2005
|
1.27
|
|
27
|
Compensatory activation of Akt in response to mTOR and Raf inhibitors - a rationale for dual-targeted therapy approaches in neuroendocrine tumor disease.
|
Cancer Lett
|
2010
|
1.27
|
|
28
|
The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes.
|
Diabetes
|
2012
|
1.26
|
|
29
|
68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors.
|
J Nucl Med
|
2010
|
1.26
|
|
30
|
Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus.
|
PLoS One
|
2010
|
1.26
|
|
31
|
The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease.
|
Inflamm Bowel Dis
|
2005
|
1.26
|
|
32
|
Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort.
|
PLoS One
|
2012
|
1.25
|
|
33
|
Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells.
|
J Cell Biochem
|
2006
|
1.25
|
|
34
|
DUG is a novel homologue of translation initiation factor 4G that binds eIF4A.
|
Biochem Biophys Res Commun
|
2002
|
1.22
|
|
35
|
IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.
|
Am J Physiol Gastrointest Liver Physiol
|
2007
|
1.21
|
|
36
|
Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis.
|
Am J Gastroenterol
|
2010
|
1.20
|
|
37
|
The role of interleukin-22 in hepatitis C virus infection.
|
Cytokine
|
2008
|
1.20
|
|
38
|
OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer.
|
Clin Cancer Res
|
2008
|
1.20
|
|
39
|
Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors.
|
J Mol Med (Berl)
|
2008
|
1.19
|
|
40
|
The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
|
Am J Gastroenterol
|
2007
|
1.18
|
|
41
|
Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours.
|
Eur J Nucl Med Mol Imaging
|
2009
|
1.18
|
|
42
|
Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells.
|
Biochem Biophys Res Commun
|
2006
|
1.17
|
|
43
|
Endogenous GLP-1 regulates postprandial glycemia in humans: relative contributions of insulin, glucagon, and gastric emptying.
|
J Clin Endocrinol Metab
|
2010
|
1.17
|
|
44
|
Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results.
|
Eur J Nucl Med Mol Imaging
|
2002
|
1.16
|
|
45
|
Correlation of magnetic resonance enteroclysis (MRE) and wireless capsule endoscopy (CE) in the diagnosis of small bowel lesions in Crohn's disease.
|
Inflamm Bowel Dis
|
2008
|
1.16
|
|
46
|
Comprehensive analysis of β-catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/β-catenin signaling.
|
BMC Genomics
|
2014
|
1.16
|
|
47
|
Hepatosplenic T-cell lymphoma in a patient with Crohn's disease.
|
Nat Rev Gastroenterol Hepatol
|
2009
|
1.15
|
|
48
|
Type 2 diabetes mellitus as risk factor for colorectal cancer.
|
Arch Physiol Biochem
|
2008
|
1.15
|
|
49
|
Interleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease.
|
Gut
|
2007
|
1.12
|
|
50
|
Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn's disease in clinical practice: results of a prospective study.
|
Inflamm Bowel Dis
|
2006
|
1.11
|
|
51
|
A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins.
|
J Biol Chem
|
2011
|
1.11
|
|
52
|
A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents.
|
Regul Pept
|
2006
|
1.10
|
|
53
|
Resistin is an inflammatory marker of inflammatory bowel disease in humans.
|
Eur J Gastroenterol Hepatol
|
2007
|
1.09
|
|
54
|
Role of fat hydrolysis in regulating glucagon-like Peptide-1 secretion.
|
J Clin Endocrinol Metab
|
2009
|
1.08
|
|
55
|
The effect of telmisartan on glucose and lipid metabolism in nondiabetic, insulin-resistant subjects.
|
Metabolism
|
2006
|
1.08
|
|
56
|
Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
|
Am J Gastroenterol
|
2006
|
1.08
|
|
57
|
DRO1, a gene down-regulated by oncogenes, mediates growth inhibition in colon and pancreatic cancer cells.
|
J Biol Chem
|
2004
|
1.07
|
|
58
|
Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene.
|
Mol Ther
|
2011
|
1.07
|
|
59
|
Evidence for STAT4 as a common autoimmune gene: rs7574865 is associated with colonic Crohn's disease and early disease onset.
|
PLoS One
|
2010
|
1.06
|
|
60
|
Risk of advanced colorectal neoplasia according to age and gender.
|
PLoS One
|
2011
|
1.05
|
|
61
|
Cost-effectiveness of KRAS testing in metastatic colorectal cancer patients in the United States and Germany.
|
Int J Cancer
|
2012
|
1.04
|
|
62
|
SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells.
|
Cancer Res
|
2007
|
1.04
|
|
63
|
The physiological role of GLP-1 in human: incretin, ileal brake or more?
|
Regul Pept
|
2005
|
1.02
|
|
64
|
Relative roles of the different Pax6 domains for pancreatic alpha cell development.
|
BMC Dev Biol
|
2010
|
1.02
|
|
65
|
Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet.
|
Diabetes
|
2010
|
1.02
|
|
66
|
Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide.
|
Diabetes Care
|
2008
|
1.02
|
|
67
|
Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques.
|
PLoS One
|
2009
|
1.01
|
|
68
|
Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
|
Am J Physiol Renal Physiol
|
2009
|
1.01
|
|
69
|
Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis.
|
Scand J Gastroenterol
|
2006
|
1.01
|
|
70
|
Diabetes mellitus and gastric emptying: questions and issues in clinical practice.
|
Diabetes Metab Res Rev
|
2009
|
1.01
|
|
71
|
Sodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188)Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene delivery.
|
Hum Gene Ther
|
2011
|
1.01
|
|
72
|
A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine.
|
J Hepatol
|
2005
|
1.00
|
|
73
|
Immune sensitization to yeast antigens in ASCA-positive patients with Crohn's disease.
|
Inflamm Bowel Dis
|
2004
|
1.00
|
|
74
|
Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression.
|
J Clin Endocrinol Metab
|
2007
|
1.00
|
|
75
|
Eight novel CARD15 variants detected by DNA sequence analysis of the CARD15 gene in 111 patients with inflammatory bowel disease.
|
Immunogenetics
|
2006
|
1.00
|
|
76
|
IRGM variants and susceptibility to inflammatory bowel disease in the German population.
|
PLoS One
|
2013
|
0.98
|
|
77
|
The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.98
|
|
78
|
Cannabinoid-1 (CB1) receptors regulate colonic propulsion by acting at motor neurons within the ascending motor pathways in mouse colon.
|
Am J Physiol Gastrointest Liver Physiol
|
2008
|
0.97
|
|
79
|
Infliximab for acute, not steroid-refractory ulcerative colitis: a randomized pilot study.
|
Eur J Gastroenterol Hepatol
|
2004
|
0.96
|
|
80
|
MMP-1 serum levels predict coronary atherosclerosis in humans.
|
Cardiovasc Diabetol
|
2009
|
0.96
|
|
81
|
Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis.
|
J Cell Mol Med
|
2014
|
0.96
|
|
82
|
Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2).
|
J Hepatol
|
2007
|
0.95
|
|
83
|
Analysis of IL12B gene variants in inflammatory bowel disease.
|
PLoS One
|
2012
|
0.94
|
|
84
|
Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.
|
Clin Cancer Res
|
2009
|
0.94
|
|
85
|
Insulin glargine and NPH insulin increase to a similar degree epithelial cell proliferation and aberrant crypt foci formation in colons of diabetic mice.
|
Horm Cancer
|
2010
|
0.94
|
|
86
|
A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
|
J Clin Endocrinol Metab
|
2005
|
0.94
|
|
87
|
Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.
|
Breast Cancer Res Treat
|
2007
|
0.93
|
|
88
|
Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene delivery.
|
Mol Ther
|
2011
|
0.93
|
|
89
|
Serum concentrations of cortisol, interleukin 6, leptin and adiponectin predict stress induced insulin resistance in acute inflammatory reactions.
|
Crit Care
|
2008
|
0.93
|
|
90
|
Regulation of HSP60 and the role of MK2 in a new model of severe experimental pancreatitis.
|
Am J Physiol Gastrointest Liver Physiol
|
2009
|
0.93
|
|
91
|
Expression, cellular distribution, and prognostic relevance of TRAIL receptors in hepatocellular carcinoma.
|
Clin Cancer Res
|
2010
|
0.93
|
|
92
|
Inhibition of ataxia telangiectasia- and Rad3-related function abrogates the in vitro and in vivo tumorigenicity of human colon cancer cells through depletion of the CD133(+) tumor-initiating cell fraction.
|
Stem Cells
|
2011
|
0.93
|
|
93
|
Gene deletion of MK2 inhibits TNF-alpha and IL-6 and protects against cerulein-induced pancreatitis.
|
Am J Physiol Gastrointest Liver Physiol
|
2006
|
0.92
|
|
94
|
Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma.
|
Digestion
|
2007
|
0.92
|
|
95
|
CRHSP-24 phosphorylation is regulated by multiple signaling pathways in pancreatic acinar cells.
|
Am J Physiol Gastrointest Liver Physiol
|
2003
|
0.92
|
|
96
|
Acute hyperglycemia alters the ability of the normal beta-cell to sense and respond to glucose.
|
Am J Physiol Endocrinol Metab
|
2002
|
0.91
|
|
97
|
Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease.
|
Inflamm Bowel Dis
|
2007
|
0.91
|
|
98
|
Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome.
|
Cardiovasc Diabetol
|
2006
|
0.91
|
|
99
|
Dickkopf-4 is frequently down-regulated and inhibits growth of colorectal cancer cells.
|
Cancer Lett
|
2008
|
0.91
|
|
100
|
Overexpression of heat shock protein Hsp27 protects against cerulein-induced pancreatitis.
|
Gastroenterology
|
2004
|
0.91
|
|
101
|
Tauroursodeoxycholic acid reduces endoplasmic reticulum stress, acinar cell damage, and systemic inflammation in acute pancreatitis.
|
Am J Physiol Gastrointest Liver Physiol
|
2011
|
0.90
|
|
102
|
rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population.
|
Am J Gastroenterol
|
2009
|
0.90
|
|
103
|
Treatment with octreotide does not reduce tumor uptake of (68)Ga-DOTATATE as measured by PET/CT in patients with neuroendocrine tumors.
|
J Nucl Med
|
2011
|
0.90
|
|
104
|
Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced β-cell mass.
|
Diabetes
|
2012
|
0.90
|
|
105
|
Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene.
|
J Nucl Med
|
2013
|
0.90
|
|
106
|
Are gap junctions truly involved in inhibitory neuromuscular interaction in mouse proximal colon?
|
Clin Exp Pharmacol Physiol
|
2006
|
0.89
|
|
107
|
Free fatty acids sensitize hepatocytes to bile acid-induced apoptosis.
|
Biochem Biophys Res Commun
|
2008
|
0.89
|
|
108
|
Image-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene.
|
Hum Gene Ther
|
2011
|
0.88
|
|
109
|
Postnatal development of numbers and mean sizes of pancreatic islets and beta-cells in healthy mice and GIPR(dn) transgenic diabetic mice.
|
PLoS One
|
2011
|
0.88
|
|
110
|
The NOD2 single nucleotide polymorphisms rs2066843 and rs2076756 are novel and common Crohn's disease susceptibility gene variants.
|
PLoS One
|
2010
|
0.88
|
|
111
|
P60-c-src suppresses apoptosis through inhibition of caspase 8 activation in hepatoma cells, but not in primary hepatocytes.
|
J Hepatol
|
2006
|
0.87
|
|
112
|
Defining the role of GLP-1 in the enteroinsulinar axis in type 2 diabetes using DPP-4 inhibition and GLP-1 receptor blockade.
|
Diabetes
|
2013
|
0.87
|
|
113
|
Novel insulin sensitizers: pharmacogenomic aspects.
|
Pharmacogenomics
|
2002
|
0.87
|
|
114
|
γ-Catenin is an independent prognostic marker in early stage colorectal cancer.
|
Int J Colorectal Dis
|
2010
|
0.86
|
|
115
|
A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice.
|
Neuropharmacology
|
2013
|
0.86
|
|
116
|
Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents.
|
Mol Cancer
|
2010
|
0.86
|
|
117
|
Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies.
|
Pharmacoepidemiol Drug Saf
|
2014
|
0.86
|
|
118
|
Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease.
|
Clin Immunol
|
2008
|
0.86
|
|
119
|
Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy.
|
Eur J Gastroenterol Hepatol
|
2006
|
0.86
|
|
120
|
The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease.
|
PLoS One
|
2010
|
0.86
|
|
121
|
Selectively N-methylated soluble IAPP mimics as potent IAPP receptor agonists and nanomolar inhibitors of cytotoxic self-assembly of both IAPP and Aβ40.
|
Angew Chem Int Ed Engl
|
2013
|
0.85
|
|
122
|
The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn's disease independent of the IL23R genotype.
|
J Gastroenterol
|
2010
|
0.85
|
|
123
|
Pregnane X receptor (PXR/NR1I2) gene haplotypes modulate susceptibility to inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2010
|
0.85
|
|
124
|
Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma.
|
J Cell Mol Med
|
2012
|
0.85
|
|
125
|
Chromogranin a as serum marker for gastroenteropancreatic neuroendocrine tumors: a single center experience and literature review.
|
Cancers (Basel)
|
2012
|
0.85
|
|
126
|
PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease background.
|
PLoS One
|
2012
|
0.85
|
|
127
|
The novel Raf inhibitor Raf265 decreases Bcl-2 levels and confers TRAIL-sensitivity to neuroendocrine tumour cells.
|
Endocr Relat Cancer
|
2011
|
0.85
|
|
128
|
Portal pressure regulation following Kupffer cell activation: control of prostaglandin production by heme oxygenases.
|
Digestion
|
2013
|
0.85
|
|
129
|
Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells.
|
Int J Oncol
|
2013
|
0.85
|
|
130
|
4-Phenylbutyric acid reduces endoplasmic reticulum stress, trypsin activation, and acinar cell apoptosis while increasing secretion in rat pancreatic acini.
|
Pancreas
|
2013
|
0.84
|
|
131
|
Severe Legionella pneumophila pneumonia following infliximab therapy in a patient with Crohn's disease.
|
Inflamm Bowel Dis
|
2009
|
0.84
|
|
132
|
A direct comparison of the prevalence of advanced adenoma and cancer between surveillance and screening colonoscopies.
|
Digestion
|
2013
|
0.84
|
|
133
|
Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease.
|
Digestion
|
2011
|
0.83
|
|
134
|
CEACAM6 gene variants in inflammatory bowel disease.
|
PLoS One
|
2011
|
0.83
|
|
135
|
Activation of cannabinoid receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms.
|
Am J Physiol Gastrointest Liver Physiol
|
2012
|
0.83
|
|
136
|
HYDRA: possible determinants of unsatisfactory hypertension control in German primary care patients.
|
Blood Press
|
2004
|
0.83
|
|
137
|
EGFR-Targeted Adenovirus Dendrimer Coating for Improved Systemic Delivery of the Theranostic NIS Gene.
|
Mol Ther Nucleic Acids
|
2013
|
0.83
|
|
138
|
Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
|
Am J Gastroenterol
|
2002
|
0.83
|
|
139
|
Calcitonin receptor-like receptor is expressed on gastrointestinal immune cells.
|
Digestion
|
2002
|
0.82
|
|
140
|
Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2007
|
0.82
|
|
141
|
Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma.
|
Hum Gene Ther
|
2013
|
0.82
|
|
142
|
Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of ¹³¹I by carbamazepine in breast cancer cells.
|
Breast Cancer Res Treat
|
2010
|
0.82
|
|
143
|
Microsatellite instability, KRAS mutations and cellular distribution of TRAIL-receptors in early stage colorectal cancer.
|
PLoS One
|
2012
|
0.82
|
|
144
|
Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgery.
|
PLoS One
|
2013
|
0.82
|
|
145
|
ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
|
Gastroenterology
|
2009
|
0.81
|
|
146
|
Anticancer effects of metformin on neuroendocrine tumor cells in vitro.
|
Hormones (Athens)
|
2014
|
0.80
|
|
147
|
Role of PPARG gene variants in inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2010
|
0.80
|
|
148
|
Do we underestimate capsule endoscopy in the upper gastrointestinal tract?
|
Digestion
|
2005
|
0.80
|
|
149
|
No non-redundant function of suppressor of cytokine signaling 2 in insulin producing β-cells.
|
Islets
|
2010
|
0.80
|
|
150
|
Double-balloon enteroscopy versus magnetic resonance enteroclysis in diagnosing suspected small-bowel Crohn's disease: results of a pilot study.
|
Scand J Gastroenterol
|
2007
|
0.80
|
|
151
|
Effect of sleeve gastrectomy on postprandial lipoprotein metabolism in morbidly obese patients.
|
Lipids Health Dis
|
2013
|
0.79
|
|
152
|
Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms.
|
Endocr Relat Cancer
|
2012
|
0.79
|
|
153
|
Treatment with the leukotriene inhibitor montelukast for 10 days attenuates portal hypertension in rat liver cirrhosis.
|
Hepatology
|
2010
|
0.79
|
|
154
|
Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2.
|
PLoS One
|
2013
|
0.79
|
|
155
|
Risk factors for advanced neoplasia within subcentimetric polyps: implications for diagnostic imaging.
|
Gut
|
2012
|
0.79
|
|
156
|
Combination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude mice.
|
Endocrinology
|
2014
|
0.79
|
|
157
|
Safety of adalimumab in Crohn's disease during pregnancy: case report and review of the literature.
|
Inflamm Bowel Dis
|
2010
|
0.79
|
|
158
|
The transcription factor ITF-2A induces cell cycle arrest via p21(Cip1).
|
Biochem Biophys Res Commun
|
2009
|
0.78
|
|
159
|
Diabetes mellitus and exocrine pancreatic function.
|
Digestion
|
2005
|
0.78
|
|
160
|
Analysis of IL2/IL21 gene variants in cholestatic liver diseases reveals an association with primary sclerosing cholangitis.
|
Digestion
|
2011
|
0.78
|
|
161
|
Photodynamic therapy for cholangiocarcinoma using low dose mTHPC (Foscan(®)).
|
Photodiagnosis Photodyn Ther
|
2013
|
0.78
|
|
162
|
Functional relevance of the cannabinoid receptor 2 - heme oxygenase pathway: a novel target for the attenuation of portal hypertension.
|
Life Sci
|
2013
|
0.78
|
|
163
|
Does ursodeoxycholic acid change the proliferation of the colorectal mucosa?. A randomized, placebo-controlled study.
|
Digestion
|
2003
|
0.77
|
|
164
|
Kupffer cell activation by hydrogen peroxide: a new mechanism of portal pressure increase.
|
Shock
|
2010
|
0.77
|
|
165
|
ORL-1 receptor mediates the action of nociceptin on ascending myenteric reflex pathways in rats.
|
Gastroenterology
|
2007
|
0.77
|
|
166
|
Formation of antinuclear and double-strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF-α antibody-treated patients with inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2011
|
0.77
|
|
167
|
GLP-1--a candidate humoral mediator for glucose control after Roux-en-Y gastric bypass.
|
Diabetes
|
2014
|
0.76
|
|
168
|
Diets influence the diabetic phenotype of transgenic mice expressing a dominant negative glucose-dependent insulinotropic polypeptide receptor (GIPRdn).
|
Regul Pept
|
2007
|
0.76
|
|
169
|
Are incretin mimetics and enhancers linked to pancreatitis and malignant transformations in pancreas?
|
Expert Opin Drug Saf
|
2014
|
0.76
|
|
170
|
Medical treatment of gastrinomas.
|
Wien Klin Wochenschr
|
2007
|
0.76
|
|
171
|
Increased prevalence of colorectal adenomas in women with breast cancer.
|
Digestion
|
2005
|
0.76
|
|
172
|
The novel somatostatin receptor 2/dopamine type 2 receptor chimeric compound BIM-23A758 decreases the viability of human GOT1 midgut carcinoid cells.
|
Neuroendocrinology
|
2013
|
0.76
|
|
173
|
[A 27-year-old patient with recurrent Fever].
|
Med Klin (Munich)
|
2003
|
0.76
|
|
174
|
Assessment of colon motility using simultaneous manometric and functional cine-MRI analysis: preliminary results.
|
Abdom Imaging
|
2011
|
0.76
|
|
175
|
Stomach and gallbladder under fat control?
|
Digestion
|
2007
|
0.75
|
|
176
|
Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design.
|
Diabetes Metab Syndr Obes
|
2009
|
0.75
|
|
177
|
GLP-1 analogues: a new therapeutic approach to prevent ductopenia in cholangiopathies?
|
Gut
|
2009
|
0.75
|
|
178
|
Enterothorax mimicking pleural effusion.
|
Indian J Gastroenterol
|
2006
|
0.75
|
|
179
|
Identification of a novel inactivating R465Q mutation of the calcium-sensing receptor.
|
Biochem Biophys Res Commun
|
2006
|
0.75
|
|
180
|
Addition of local hepatic therapy to sorafenib in patients with advanced hepatocellular carcinoma (stage BCLC C).
|
Digestion
|
2014
|
0.75
|
|
181
|
Pharmacogenetics of Crohn's disease.
|
Pharmacogenomics
|
2008
|
0.75
|
|
182
|
[Improved blood sugar control plus weight loss].
|
MMW Fortschr Med
|
2006
|
0.75
|
|
183
|
Role of cysteinyl-leukotrienes for portal pressure regulation and liver damage in cholestatic rat livers.
|
Lab Invest
|
2013
|
0.75
|
|
184
|
Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition.
|
Neuroendocrinology
|
2015
|
0.75
|
|
185
|
[Obstructive jaundice: harmless stone or malignant tumour? Diagnosis and management from a gastroenterologist's perspective].
|
MMW Fortschr Med
|
2009
|
0.75
|